InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-20.9%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Rossi Michael A., Chief Financial Officer. Insider active across 2 companies, notably HARVARD BIOSCIENCE INC. In total, 10 reports have been published. History available since 11 June 2021. The latest transaction was disclosed on 29 December 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
3,162 shares@ US$2.5523.2% of flowCommon StockSEC:0000921895-23-000013:0
7,008 shares@ US$3.6376.8% of flowCommon StockSEC:0000921895-22-002258:0
6,325 shares@ US$3.950.079% mcap15.3% of flowCommon StockSEC:0000921895-22-001987:0
31,021 shares0Common StockSEC:0001193805-22-000420:0
3,163 shares@ US$7.270.068% mcap13.2% of flowCommon StockSEC:0000921895-22-000035:0
3,163 shares@ US$7.2713.2% of flowCommon StockSEC:0000921895-22-000035
6,966 shares@ US$7.5729.1% of flowCommon StockSEC:0000921895-21-001884
6,966 shares@ US$7.570.15% mcap29.1% of flowCommon StockSEC:0000921895-21-001884:0
21,546 shares0Common StockSEC:0000921895-21-001649
21,546 shares0Common StockSEC:0000921895-21-001649:0
10 of 10 declarations
About Rossi Michael A.
Michael A. Rossi is the Chief Financial Officer at Harvard Bioscience Inc. He oversees the financial operations of the company, including financial planning and risk management. His role is essential in ensuring the financial health and growth of the company.
